Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Diamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103420878B reveals high-purity diamine monomer synthesis. Enhances polyimide dielectric properties. Reliable supply chain and cost-effective manufacturing solutions available.
Patent CN1483017A details a high-purity synthesis of 1,5-naphthalenediamine from o-nitrotoluene, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN112898198B reveals a novel Suzuki coupling route for synthesizing high-purity nitrogen-containing aromatic heterocyclic diamines, offering significant cost reduction and scalability for polyimide manufacturing.
Patent CN111138424B discloses a novel diamine monomer enhancing polyimide fluorescence. We offer scalable synthesis for advanced electronic materials.
Patent CN1487916A details an improved method for beta-3 agonist intermediates, offering higher yields and streamlined manufacturing for reliable pharmaceutical suppliers.
Patent CN112110827B reveals a novel diamine enabling colorless polyimide films with high thermal stability and modulus for advanced flexible display manufacturing.
Patent CN114591273A reveals a solid-state synthesis route for high-purity Alfuzosin intermediates, offering superior stability and cost reduction in pharmaceutical manufacturing.
Patent CN114539166B reveals low dielectric loss diamine monomer. Enhances polyimide film performance with cost-effective ionic liquid catalysis.
Patent CN113620814B reveals a green oxidative route for fluorinated diamines. This method ensures high purity and supply chain stability for electronic material manufacturing.
Patent CN107827756A reveals catalyst reducing N-methyl impurities. Enhances supply chain reliability and cost efficiency for global buyers.
Novel one-step chlorination process reduces cost and waste for dye and polymer intermediates supply chain efficiency and purity standards globally.
Patent CN117510342A reveals improved 2,4-MDA selectivity via multi-step acid catalysis. Enhances supply chain stability and reduces manufacturing costs for global buyers.
Patent CN117069660A enables green benzimidazole synthesis using supercritical CO2. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN109912426B reveals a cost-effective route for (2R,5R)-1,6-diphenyl-2,5-hexanediamine. Discover scalable manufacturing solutions for HIV drug intermediates.
Patent CN117209383B reveals a low-waste phenylenediamine method. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable solutions.
Novel enzymatic synthesis method for high-purity chiral cis-cyclohexanediamine. Scalable process reduces impurities and ensures supply chain reliability for anticoagulant manufacturing.
Patent CN1583752A details a novel SnCl2-assisted synthesis for benzoxazole diamines, offering superior yields and purity for optical polymer manufacturing.
Patent CN112679365A reveals a scalable 4-step synthesis for 6-bromonaphthalene-1,2-diamine, a key HCV inhibitor intermediate, offering cost-effective manufacturing solutions.
Patent CN108017547A reveals a continuous multi-stage bubble column method for IPDA synthesis, offering enhanced cis-trans ratios and reduced waste for reliable supply chains.
Patent CN106631856B details a novel nitrogen mustard derivative with reduced toxicity. This report analyzes scalable synthesis and supply chain advantages for pharmaceutical intermediates.